The DOI matches its Crossref record; 59 of the 62 references it cites were found in a registry or an index; 33 of the 55 sources its claims cite were checked for support.
Baseline Pro-Inflammatory Cytokine Levels Moderate Psychological Inflexibility in Behavioral Treatment for Chronic Pain
Open accessAbstract
Background: The medical and scientific communities struggle to understand chronic pain and find effective treatments. Multimodal approaches are encouraging but show significant individual differences. Methods: Seventy-eight persons (56 women) with chronic pain received Acceptance and Commitment Therapy and provided blood samples before and after treatment. The participants completed surveys with the blood sampling. Blood plasma was analyzed for IL-6 and TNF-α levels with the Olink Inflammation Panel (Olink Bioscience Uppsala, Sweden). The treatment effects and moderating effects of low-grade inflammation on changes in outcomes were analyzed using linear mixed models. Results: Pain interference (p < 0.001) and psychological inflexibility (p < 0.001) improved significantly during treatment, but pain intensity did not (p = 0.078). Cytokine levels did not change over the course of the treatment (IL-6/TNF-α p = 0.086/0.672). Mean baseline levels of IL-6 and TNF-α moderated improvement in psychological inflexibility during the course of treatment (p = 0.044), but cytokine levels did not moderate changes in pain interference (p = 0.205) or pain intensity (p = 0.536). Conclusions: Higher baseline inflammation levels were related to less improvement in psychological inflexibility. Low-grade inflammation may be one factor underlying the variability in behavioral treatment in chronic pain. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.
Overview
CoChat Summary
## TL;DR
In 78 people with chronic pain receiving ACT, pain interference and psychological inflexibility improved, but pain intensity and cytokine levels did not. Baseline low-grade inflammation (mean IL-6 and TNF-α) moderated change in psychological inflexibility, with higher inflammation linked to less improvement.
## Key findings
- In the analyzed sample, 78 persons with chronic pain were included; 56 were women, 56 received internet-based treatment, and 22 received face-to-face treatment.
- During treatment, pain interference improved significantly (β = −4.729, p < 0.001) and psychological inflexibility improved significantly (β = −7.166, p < 0.001), while pain intensity did not (p = 0.078).
- IL-6 and TNF-α levels did not decrease over time (p = 0.086 and p = 0.672, respectively).
- Mean baseline IL-6/TNF-α levels moderated change in psychological inflexibility during treatment (β = 14.624, p = 0.044), but did not moderate pain interference (p = 0.205) or pain intensity (p = 0.536).
## Methods
- Participants with chronic pain were recruited between 2016–2018 through referrals to Behavioral Pain Medicine Treatment Services at Karolinska University Hospital or advertising; inclusion required age ≥18, pain > 6 consecutive months, stable medication, and Swedish fluency, with exclusions for concurrent CBT, severe psychiatric comorbidity, and some phlebotomy-related conditions.
- All participants received Acceptance and Commitment Therapy, either face-to-face over 3 months or internet-delivered over 10 weeks; questionnaires and blood samples were collected before and after treatment.
- IL-6 and TNF-α were assayed from plasma using the Olink Inflammation Panel, and treatment and moderation effects were tested with linear mixed models using maximum likelihood estimation and covariate adjustment.
## Limitations
- The paper states a major limitation was the lack of a randomized controlled design and a control group, which prevents comparison with untreated or healthy groups and makes spontaneous change difficult to rule out.
- The authors note the sample included mixed pain diagnoses and the primary pain diagnosis was not available; they also note variability in treatment format.
- Evident from the text: some baseline questionnaire data were missing for the first six patients, and 9 of 78 included participants were excluded from the analysis because questionnaire and blood-sampling timing differed by more than 14 days.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
20 Valid · 1 Not valid · 11 Not checked · 39 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“ACT does not primarily target pain intensity or related symptoms, but rather the influence of pain on a person’s daily life [11], as assessed by, e.g., The Pain Interference Index (PII) [18].”
§ Baseline Pro-Inflammatory Cytokine Levels Moderate Psychological Inflexibility in Behavioral Treatment for Chronic Pain > 1. Introduction Chronic pain is common, with studies showing prevalence rates of about one in five adults suffering from chronic pain [1]. In addition to a significant impact on emotional well-being and everyday functioning for the many affected, chronic pain is related to substantial societal costs [1,2]. The medical and scientific communities are still struggling to understand the mechanisms underlying the onset and perpetuation of symptoms and find effective treatment strategies. A number of classifications and diagnoses exist, and individual differences in symptom severity and disability are significant even within a specific pain diagnosis [2,3,4], adding to the complexity of the condition. However, some commonalities are seen across chronic pain diagnoses, such as a considerable overlap between chronic pain and psychological suffering [1,2,4]. Increased peripheral and central inflammatory activity has also been demonstrated across a wide range of pain diagnoses [5], such as fibromyalgia [6], neuropathic pain [7] and low back pain [8]. Modern pain treatment acknowledges the complexity of chronic pain disorders and attempts to ease patient suffering with multimodal and individualized approaches. There is a broad consensus on the utility of behavioral interventions to alleviate symptoms and improve health and functioning [9]. However, it is also well known that individuals vary in their response to treatment [9], which calls for a better understanding of the factors influencing treatment outcomes to guide the development of customized interventions with better effects [10]. In the present study, the participants underwent Acceptance and Commitment Therapy (ACT). This exposure-oriented behavioral intervention utilizes acceptance and values-based behavioral strategies to promote the ability to engage in valued activities despite the presence of pain and distress [11,12]. This ability is called psychological (or behavioral) flexibility [13]. Psychological inflexibility, as assessed with, e.g., Psychological Inflexibility in Pain Scale (PIPS) [14], is thus a central treatment target in ACT. Psychological inflexibility is characterized by rigid behavioral repertoires aimed at avoiding pain and related distress [14,15], which may work well in the short term, but over time result in a gradual decrease in functioning without any corresponding alleviation of pain or distress [16]. This type of avoidance was recently shown to predict pain disability and depressive symptoms three years later [17]. ACT does not primarily target pain intensity or related symptoms, but rather the influence of pain on a person’s daily life [11], as assessed by, e.g., The Pain Interference Index (PII) [18]. Previous studies have shown that psychological inflexibility is a more important mediator of changes in pain interference during ACT than, e.g., pain intensity [12]. Thus, by improving the ability to effectively manage pain and related distress (i.e., decrease psychological inflexibility), ACT aims to reduce avoidance strategies and facilitate a broader and more flexible behavioral repertoire in line with personal values and long-term goals (i.e., decrease pain interference). Today, ACT has strong empirical support to improve functioning for persons with chronic pain [19]. However, more studies are needed that investigate for whom, how and under what circumstances these treatment approaches work, i.e., factors that moderate treatment outcome [10]. We propose that ongoing low-grade inflammation may be one such factor. Experimentally induced inflammation in healthy humans and rodents increases pain sensitivity, decreases mood and changes motivational behaviors, see, e.g., [20,21,22,23] for an overview. Inflammatory activity has been established as a factor in clinically depressed patients [24] and has recently been highlighted as relevant in the perspective of predicting or moderating treatment outcomes in chronic pain [25] and depression [26]. For depression, low-grade inflammatory activity seems to be related to the failure of responding to pharmacological antidepressant treatments specifically [27,28]. Few studies have explored the role of inflammation in behavioral interventions for complex diseases, such as depression and pain. Moreover, only two studies have, to our knowledge, examined the predictive ability of low-grade inflammation on treatment success in chronic pain patients undergoing behavioral interventions. The present study follows a previous trial in which a group of chronic pain patients (n = 41) underwent behavioral treatment (ACT or applied relaxation). Results showed that baseline peripheral low-grade inflammation, operationalized as a combination of interleukin (IL)-6 and tumor necrosis factor (TNF)-α levels in the blood, moderated improvements in pain intensity and psychological inflexibility. Higher baseline inflammatory activity predicted a less favorable treatment outcome [25]. In a recent study in which persons with fibromyalgia participated in treatment comprising mindfulness-based stress reduction (MBSR), a higher ratio of pro- vs. anti-inflammatory cytokines (IL-6/IL-10) was associated with less improvement in psychological inflexibility during treatment [29]. In our study [25], we also saw a small decrease in inflammatory cytokine levels after treatment, which aligns with a meta-analysis on the effects of behavioral therapy on CRP blood levels [30]. In sum, studies evaluating inflammation as a factor influencing the outcome of behavioral treatment for chronic pain are scarce but suggest that inflammation may interfere with improvement. However, results from existing studies are not entirely congruent, and confirmative studies are needed. Based on our previous study [25], we hypothesized that (1) pain interference and psychological inflexibility would improve following treatment, and pain intensity decrease; (2) levels of low-grade inflammation would decrease during treatment; and (3) baseline inflammatory levels would moderate the effect of treatment on pain interference, pain intensity and psychological inflexibility.
What the sources say
- Supportedcites [11] Hayes, 2006, Acceptance and commitment therapy: Model, processes and outcomes, Behav. Res. Ther. source
The 'Six core processes of ACT' section (p. 7) identifies psychological flexibility and behavior serving valued ends—not symptom reduction—as ACT's general goal. In the pain-specific discussion, 'Research on ACT' (p. 13) links psychological flexibility more strongly than pain ratings to disability, work status, and daily activity. The cited paper thus supports the paraphrase about ACT's focus; the PII is attributed to a different citation. (LLM, conf=0.90)
- Supportedcites [18] Kemani, 2016, A validation of the pain interference index in adults with long-standing pain, Acta Anaesthesiol. Scand. source
The citation to this paper is attached to the Pain Interference Index (PII), not to the preceding statement about ACT. The Pain interference section describes the PII as measuring how pain affects activities and central aspects of daily life, which supports its use as the example in the citing sentence. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Inflammatory levels did not moderate changes in pain interference (p = 0.205) or pain intensity (p = 0.536) (Table 4).”
- Also stated in: § Abstract · plain
“Mean baseline levels of IL-6 and TNF-α moderated improvement in psychological inflexibility during the course of treatment (p = 0.044), but cytokine levels did not moderate changes in pain interference (p = 0.205) or pain intensity (p = 0.536).”
§ Baseline Pro-Inflammatory Cytokine Levels Moderate Psychological Inflexibility in Behavioral Treatment for Chronic Pain > 3. Results > 3.3. Effect of Inflammation on Treatment Outcomes
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, pain intensity (p = 0.078) and levels of IL-6 (p = 0.086) and TNF-α (p = 0.672) did not decrease over time.”
- Also stated in: § Abstract · plain
“Cytokine levels did not change over the course of the treatment (IL-6/TNF-α p = 0.086/0.672).”
§ Baseline Pro-Inflammatory Cytokine Levels Moderate Psychological Inflexibility in Behavioral Treatment for Chronic Pain > 3. Results > 3.2. Treatment-Related Effects
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Pain interference (PII) (β = −4.729, p < 0.001) and psychological inflexibility (PIPS) (β = −7.166, p < 0.001) improved significantly during treatment (Table 3).”
- Also stated in: § Abstract · plain
“Pain interference (p < 0.001) and psychological inflexibility (p < 0.001) improved significantly during treatment, but pain intensity did not (p = 0.078).”
§ Baseline Pro-Inflammatory Cytokine Levels Moderate Psychological Inflexibility in Behavioral Treatment for Chronic Pain > 3. Results > 3.2. Treatment-Related Effects
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, pain intensity (p = 0.078) and levels of IL-6 (p = 0.086) and TNF-α (p = 0.672) did not decrease over time.”
- Also stated in: § Abstract · plain
“Pain interference (p < 0.001) and psychological inflexibility (p < 0.001) improved significantly during treatment, but pain intensity did not (p = 0.078).”
§ Baseline Pro-Inflammatory Cytokine Levels Moderate Psychological Inflexibility in Behavioral Treatment for Chronic Pain > 3. Results > 3.2. Treatment-Related Effects
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
11 more claims
Create a free account to see all 71 claims and every source verdict.
- It may state two separate claims as one. 24
- Probably not a substantial claim. 45
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7
Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.10.1092 · Cited by 31,765 · cited 1×
“Items are scored from 0 (‘Not at all’) to 3 (‘Nearly every day’) and summarized [33].”
BackgroundMultimodel Inference: Understanding AIC and BIC in Model Selection
Burnham, K. P., & Anderson, D. R. (2004) · Sociological Methods & Research · doi:10.1177/0049124104268644 · Cited by 11,648
Missing data: our view of the state of the art
Schafer, J. L., & Graham, J. W. (2002) · Psychological Methods · doi:10.1037/1082-989x.7.2.147 · Cited by 11,638 · cited 1×
“In line with the intention to treat, principle maximum likelihood estimation, an approach that uses information from all available observations, was used to estimate parameters and provides unbiased estimates and standard errors in the presence of incomplete data [35], under the assumption that data are missing at ran…”
MethodAcceptance and commitment therapy: model, processes and outcomes
Hayes, S. C., Luoma, J. B., Bond, F. W., Masuda, A., & Lillis, J. (2006) · Behaviour Research and Therapy · doi:10.1016/j.brat.2005.06.006 · Cited by 6,587 · cited 2×
“This exposure-oriented behavioral intervention utilizes acceptance and valuesbased behavioral strategies to promote the ability to engage in valued activities despite the presence of pain and distress [11,12].”
BackgroundSurvey of chronic pain in Europe: Prevalence, impact on daily life, and treatment
Breivik, H., Collett, B., Ventafridda, V., Cohen, R., & Gallacher, D. (2006) · European Journal of Pain · doi:10.1016/j.ejpain.2005.06.009 · Cited by 5,486 · cited 3×
“Chronic pain is common, with studies showing prevalence rates of about one in five adults suffering from chronic pain [1].”
BackgroundTreede, R.-D., Rief, W., Barke, A., Aziz, Q., Bennett, M. I., Benoliel, R., Cohen, M., Evers, S., Finnerup, N. B., First, M. B., et al. (2019) · Pain · doi:10.1097/j.pain.0000000000001384 · Cited by 3,478
Psychological therapies for the management of chronic pain (excluding headache) in adults
Williams, A. C. D. C., Eccleston, C., & Morley, S. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007407.pub3 · Cited by 1,634
Robbins, T. W., James, M., Owen, A. M., Sahakian, B. J., McInnes, L., & Rabbitt, P. (1994) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106735 · Cited by 1,078
Osimo, E. F., Pillinger, T., Rodriguez, I. M., Khandaker, G. M., Pariante, C. M., & Howes, O. D. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.02.010 · Cited by 937 · cited 1×
“Inflammatory activity has been established as a factor in clinically depressed patients [24] and has recently been highlighted as relevant in the perspective of predicting or moderating treatment outcomes in chronic pain [25] and depression [26].”
Background
Cited by
Zhu, C., Bai, Y., Xia, X., Zhang, M., Wu, X., Wu, Y., Bai, Y., Liu, S., Zhang, G., Hu, J., et al. (2022) · Animals · doi:10.3390/ani12243462 · Cited by 27
“Immune cells such as macrophages, T cells and B cells acting on other cells can produce IL-6, which is significantly increased during inflammatory infection [37].”
BackgroundInflammatory Blood Signature Related to Common Psychological Comorbidity in Chronic Pain
Karshikoff, B., Wåhlén, K., Åström, J., Lekander, M., Holmström, L., & Wicksell, R. K. (2023) · Biomedicines · doi:10.3390/biomedicines11030713 · Cited by 17
“Finally, if a spontaneous improvement in their pain could be expected, participants were also excluded (see [52] using the same cohort).”
BackgroundSelf-citationSanduvete-Chaves, S., Chacón-Moscoso, S., & Cano-García, F. J. (2024) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2024.111888 · Cited by 4
Åström, J., Karshikoff, B., Holmström, L., Lekander, M., Kemani, M. K., & Wicksell, R. K. (2024) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2024.107094 · Cited by 9
Self-citationHow Can Experimental Endotoxemia Contribute to Our Understanding of Pain? A Narrative Review
Benson, S., & Karshikoff, B. (2023) · NeuroImmunoModulation · doi:10.1159/000534467 · Cited by 8
Self-citation
Metadata
- Authors
- Karshikoff, B., Åström, J., Holmström, L., Lekander, M., Kemani, M. K., & Wicksell, R. K.
- Affiliations
- Karolinska Institutet (SE)
- Karolinska University Hospital (SE)
- Stockholm University (SE)
- Corresponding author
- Karshikoff, Bianka
- ORCID
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2022-04-20
- Volume
- 11
- Issue
- 9
- Pages
- 2285
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC9102370
- OpenAlex
- W4224275227
- Semantic Scholar
- 115df548022998fdcd124f1927825c05365176d5
- Cited by
- 6
- References
- 62
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 2 · 2022: 1
- FWCI
- 1.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- NORA - Norwegian Open Research Archives (submittedVersion, cc-by)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
- Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- chronic pain, psychological inflexibility, inflammatory cytokines, interleukin-6, TNF-α, low-grade inflammation, acceptance and commitment therapy, pain interference, pain intensity, treatment moderators, individual differences in treatment response, multimodal pain management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Baseline Pro-Inflammatory Cytokine Levels Moderate Psychological Inflexibility in Behavioral Treatment for Chronic Pain. https://app.cochat.ai/papers/10.3390/jcm11092285
- The paper
- Karshikoff, B., Åström, J., Holmström, L., Lekander, M., Kemani, M. K., & Wicksell, R. K. (2022). Baseline Pro-Inflammatory Cytokine Levels Moderate Psychological Inflexibility in Behavioral Treatment for Chronic Pain. Journal of Clinical Medicine. https://doi.org/10.3390/jcm11092285
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
